Catalyst Wire Dossier Catalyst Wire Dossier

Filgrastim (biosimilar)

filgrastim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Filgrastim (biosimilar), covering 2016-06-21 to 2016-06-21. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of Biosimilar Filgrastim on the Mobilization of Hematopoietic Stem Cell CD34+ (Cluster of Differentiation 34) and on the Kinetic Engraftment

See pricing